Senior Director, Head of Structural Biology

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

We are seeking a Senior Director, Head of Structural Biology, to lead the scientific strategy, team development, and operations of our Structural Biology group. The group integrates X-ray crystallography, NMR, and cryo-EM to advance oncology drug discovery through Revolution Medicines’ tri-complex molecular glue platform. You will partner closely with medicinal and computational chemistry to guide compound design and optimization, and with project teams and biologists to address structure-function relationships and mechanisms of action. Beyond individual programs, you will define the next stage of our structural biology capabilities, identifying the technologies, talent and external partnerships that will most improve discovery decisions and extend the reach of the platform. You will shape how we understand and design compound-induced protein interactions, translating molecular recognition and cooperativity and conformational dynamics into better molecules and new therapeutic opportunities for patients. This role combines deep scientific judgment with strategic leadership, cross-functional influence, and accountability for group performance and resources.

Responsibilities

- Set and execute the Structural Biology strategy in partnership with research leadership, aligning near-term program needs and long-term capability development with portfolio and platform priorities.

- Lead and develop a high-performing team of scientists across crystallography, NMR, and cryo-EM; establish clear expectations, provide coaching, and support career growth.

- Partner with medicinal, computational, and digital discovery scientists to integrate experimental structures, predictive models, and molecular simulations into actionable hypotheses that guide molecular design, structure-activity relationship interpretation, compound optimization, and experimental validation, with appropriate assessment of confidence and risk.

- Work closely with project teams and the Structural Biology group to define structure-function questions and design integrated studies with biochemistry, biophysics, and cellular biology that test mechanistic hypotheses and inform program decisions.

- Lead investigations into the molecular underpinnings of the tri-complex glue platform, including recognition of protein partners, ternary complex architecture, cooperativity, conformational dynamics, and selectivity; identify principles that inform new targets and discovery approaches.

- Direct the complementary application of crystallography, NMR, and cryo-EM, selecting approaches appropriate to each scientific question and guiding solutions to challenging protein and complex characterization problems.

- Own prioritization and resource allocation across the group, balancing program delivery with exploratory platform research.

- Model scientific rigor, integrity, and commitment to patients; build an inclusive culture of collaboration, constructive debate, accountability, and continuous learning.

Required Skills, Experience and Education:

- PhD in structural biology, biophysics, biochemistry, or a related discipline, with 12+ years biotechnology or pharmace